Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed

Daniel Berdeu, Raymond Puech, Marie-Madeleine Loubatières-Mariani, Gyslaine Bertrand

Open source

DOI
10.1016/0014-2999(96)00329-9
Published
1996-07
Container
European Journal of Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/0014-2999-96-00329-9,
  title = {Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed},
  author = {Daniel Berdeu and Raymond Puech and Marie-Madeleine Loubatières-Mariani and Gyslaine Bertrand},
  year = {1996},
  journal = {European Journal of Pharmacology},
  doi = {10.1016/0014-2999(96)00329-9},
  url = {https://doi.org/10.1016/0014-2999(96)00329-9}
}

RIS

TY  - JOUR
TI  - Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed
AU  - Daniel Berdeu
AU  - Raymond Puech
AU  - Marie-Madeleine Loubatières-Mariani
AU  - Gyslaine Bertrand
PY  - 1996
JO  - European Journal of Pharmacology
DO  - 10.1016/0014-2999(96)00329-9
UR  - https://doi.org/10.1016/0014-2999(96)00329-9
ER  - 

APA

Berdeu, D., Puech, R., Loubatières-Mariani, M., & Bertrand, G. (1996). Agmatine is not a good candidate as endogenous ligand for imidazoline sites of pancreatic B cells and vascular bed. European Journal of Pharmacology. https://doi.org/10.1016/0014-2999(96)00329-9

Source records